4//SEC Filing
Cunningham, Richard Anthony 4
Accession 0001641172-25-003095
CIK 0001815974other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 9:41 PM ET
Size
5.8 KB
Accession
0001641172-25-003095
Insider Transaction Report
Form 4
Cunningham, Richard Anthony
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2025-04-04+316,352→ 316,352 totalExercise: $1.02Exp: 2035-04-03→ Common Stock (316,352 underlying)
Footnotes (1)
- [F1]One-sixteenth (1/16) of the shares subject to the option vested and became exercisable on April 4, 2025, with the remainder scheduled to vest and become exercisable in fifteen (15) equal quarterly installments on each July 15, October 15, January 15, and April 15 thereafter, vesting fully on January 15, 2029, in each case, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
Anebulo Pharmaceuticals, Inc.
CIK 0001815974
Entity typeother
Related Parties
1- filerCIK 0001624783
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 9:41 PM ET
- Size
- 5.8 KB